By Patrick Cooney, for AMRC FEDERAL AGENCY NEWS FDA Releases Guidance on Modernizing Statistical Methods in Clinical Trials On January 12, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled Use of Bayesian Methodology in Clinical Trials of Drugs and Biologics; Draft Guidance for Industry, marking a significant step toward modernizing statistical approaches in clinical research. This guidance is now open for public comment as part of the agency’s commitment under...